Most just lately, it's been discovered that conolidine and the above mentioned derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds to some big range of endogenous opioids. Unlike most opioid receptors, this receptor acts as a scavenger and will not activate a next